Interstitial Lung Diseases: New Frontiers in Research and Clinical Applications is the book professionals working with Interstitial Lung Diseases (ILDs) have been waiting for. This comprehensive, invaluable resource integrates the pathogenic, functional, clinical, and radiological aspects of ILDs, providing clinicians with a practical tool for patient care. It elucidates on the distinguishing features of different ILDs, empowering readers to confidently navigate the diagnostic and therapeutic landscape. Sections offer a practical, step-by-step approach to diagnosing ILDs and understanding their nuances that is structured around the latest scientific evidence.
Further, the book covers etiology, epidemiology, pathogenesis, diagnostic processes, and therapeutic options, incorporating diagnostic and treatment algorithms to serve as both a reference and a practical guide for clinical decision-making. By filling gaps in the literature, it equips respiratory professionals with the knowledge and skills necessary to enhance diagnostic accuracy, improve patient management, and foster ongoing innovation in the study of ILDs.
Further, the book covers etiology, epidemiology, pathogenesis, diagnostic processes, and therapeutic options, incorporating diagnostic and treatment algorithms to serve as both a reference and a practical guide for clinical decision-making. By filling gaps in the literature, it equips respiratory professionals with the knowledge and skills necessary to enhance diagnostic accuracy, improve patient management, and foster ongoing innovation in the study of ILDs.
Table of Contents
1. Pathogenesis of ILDs general principles2. Genetics of ILDs
3. General approach to the diagnosis of ILD
4. Imaging of ILDs
5. Invasive procedures
6. Idiopathic pulmonary fibrosis
7. IPF: current and future treatments
8. Progressive Pulmonary Fibrosis (PPF)
9. Sarcoidosis
10. CTD-ILD (other than RA and SSc)
11. RA-ILD
12. SSc-ILD
13. Vasculitis-associated ILD
14. Hypersensitivity Pneumonitis
15. Smoking-related ILD
16. Eosinophilic pneumonia
17. Occupational ILD
18. Drug-induced ILD
19. Cystic ILD
20. Ultrarare ILD
21. The future of ILD diagnosis
22. Quality of life and ILD
23. Lung transplant
24. Palliative care
Authors
Carlo Vancheri University of Catania, Italy. Carlo Vancheri, MD, PhD, is a Professor of Respiratory Medicine at the University of Catania, Sicily, Italy. He heads the University of Catania Institute of Respiratory Diseases at Policlinico G. Rodolico-San Marco.He directs the Regional Referral Centre for Rare Lung Diseases, the Laboratory of Experimental Respiratory Medicine, the post-graduate School of Respiratory Diseases, and the PhD course in Translational Biomedicine. A former visiting professor at Diderot University, Paris, and research fellow at McMaster University, Canada, he holds a medical degree and postgraduate degree in Respiratory Diseases from the University of Catania and a PhD from the University of Naples.
Professor Vancheri's clinical and research interests focus on interstitial lung diseases, particularly pulmonary fibrosis, studying its pathogenesis and exploring new treatment approaches. He has been involved in various research projects and international networks, gaining expertise in precision medicine. Paolo Spagnolo School of Specialization in Respiratory Medicine, University of Padua, Italy. Paolo Spagnolo, MD, PhD, is a Full Professor of Respiratory Medicine and Head of the Respiratory Unit at the University Hospital of Padua, Italy. He directs the Residency Program in Respiratory Medicine at the University of Padua. Dr. Spagnolo completed his MD and residency at the University Hospital of Bari and joined the Royal Brompton Hospital in London in 2002. He earned his PhD from Imperial College London with a thesis on sarcoidosis genetics. He served as a research fellow and Assistant Professor at the University Hospital of Modena, focusing on rare lung diseases. From 2015 to 2024, he was an Associate Professor at the University Hospital of Padua. His research interests include idiopathic pulmonary fibrosis and sarcoidosis. Dr. Spagnolo has authored over 200 publications and is the editor-in-chief of "Sarcoidosis, Vasculitis and Diffuse Lung Diseases." He holds leadership roles in WASOG and the European Respiratory Society.
